Stay updated on Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a revised version label: Revision: v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:47:48.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Removed the funding-lapse notice that warned information on the page may not be up to date and directed users to opm.gov for status updates.
    Difference
    0.4%
    Check dated 2025-11-17T17:16:40.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the study details and sections remain unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T11:42:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Results for Pembrolizumab in untreated ENKTL have been posted, including the Complete Response Rate with related dates. The Study Protocol and Statistical Analysis Plan PDF is now available under Study Documents.
    Difference
    1%
    Check dated 2025-10-27T08:41:27.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Core content updated to show that results are now submitted/available instead of none being posted.
    Difference
    0.1%
    Check dated 2025-10-13T02:53:54.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T17:20:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.